Here are the top 5 articles for the month of November.
Hi, this is Laura Joszt for The American Journal of Managed Care®. Here are the top 5 articles for the month of November.
Number 5: Data presented at the 2019 American Heart Association Scientific Sessions may have answered how a purified fish oil pill reduces cardiovascular events. The research suggests the pill helps slow the advance of various coronary plaques.
Number 4: At the American Society of Nephrology's Kidney Week 2019 investigators presented data about 3 phase 3 trials of roxadustat. The trials showed promising results about the first-in-class oral drug to treat chronic kidney disease in patients with anemia.
Number 3: First Stop Health’s inaugural 2019 Health Benefits Cost Containment Report found that reigning in benefits spending is a top priority for employers, but many lack the data necessary to make effective changes.
Number 2: Results from ISCHEMIA, presented at the American Heart Association Scientific Sessions, showed invasive procedures like stents are often no better than medical therapy and lifestyle changes at preventing a heart attack in patients with stable heart disease.
Number 1: CMS has launched the process to craft what will come after the Oncology Care Model, the 5-year alternative payment model that ends in 2021. The successor, Oncology Care First, would include a prospective, monthly population payment; accountability for total costs of care incurred over a 6-month episode; changes to make attribution more predictable, and electronic patient-reported outcomes.
To read all of these articles and more, visit ajmc.com.
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma, R/R DLBCL
March 25th 2024The FDA issued complete response letters (CRLs) for the biologics license application for odronextamab in relapsed/refractory (R/R) follicular lymphoma and in R/R diffuse large B-cell lymphoma (DLBCL).
Read More
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More